LYFT vs TRDA · P/E 108, rev $5.79B vs P/E 12, rev $210.8M
LYFT Inc (LYFT) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
LYFT Inc (LYFT) is a software - application company listed on US. It is led by David Risher.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported LYFT revenue for 2024-12-31 was $5.79B. Net income was $22.8M. Revenue was up 31.4% from 2023-12-31 to 2024-12-31. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
LYFT currently screens at market cap $6.79B and trailing P/E 107.7. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the LYFT and TRDA stock pages for the full models.
Not investment advice.